Second time a charm as the House approves the bill at the federal level
Las Vegas, Nevada, April 4, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Hemp, Inc. (OTC PINK: HEMP) reports today that the United States House of Representatives approved legislation on Friday, April 1, 2022, to legalize marijuana at the federal level. Under the MORE Act, cannabis would be removed from the list of drugs regulated by the Controlled Substances Act, criminal penalties for federal cannabis offenses would be removed, and prior federal cannabis convictions would be expunged. HR 3617 (the MORE Act) will now go to the Senate to be voted on, debated or amended.
According to Marijuana Moment, “The vote largely aligned along party lines with only three Republicans supporting the measure and two Democrats opposing it. After an hour of debate on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act of House Judiciary Chairman Jerrold Nadler (D-NY) — and approving two amendments and rejecting a third — the full house voted 220-204 to end the federal ban on cannabis and promote social equity in the industry.
Hopes are optimistic that the second time around will be a charm with a Senate endorsement. The MORE Act was approved by the House of Representatives in December 2020, but the bill was not heard or voted on in the Senate. According to Marijuana Movement, when the MORE Act was introduced 2 years ago, it passed by a vote of 228 to 164, with five Republicans joining their fellow Democrats in pushing the reform forward. Now that it has passed the House, the MORE Act will need 60 votes to pass the Senate.
As Hemp, Inc. reported last week, deprogramming news of this magnitude showed a spike in cannabis stock market prices and trading volume. Cannabis has been a Schedule 1 controlled substance for 52 years. According to Forbes, “Cannabis is legal for adult use in 19 states and for medical use in 36 states. This bill would end the federal ban, but leave legalization to the states. According to Fortune Business Insights, “The global cannabis market is expected to grow from $28.266 billion in 2021 to $197.74 billion in 2028.”
Hemp, Inc. has released two of its strongest products to date. On March 22, 2022, Hemp, Inc. unveiled a tincture with 4 times the potency of most other hemp-derived tinctures currently on the market and at a fraction of the price. Two days later, the company released a high-potency CBD/CBG blend in capsule form and offered free sample packs. (plus shipping and handling) to the first 100 customers who ordered it from the King of Hemp website.
King of Hemp® Potent Capsules from Hemp, Inc. promote improved mood and clarity with rejuvenating properties. Some users have reported feeling rejuvenated, stress-free, and tension-free. All King of Hemp® products, including capsules, are independently tested by a third-party laboratory and manufactured in the USA at Hemp, Inc.’s manufacturing facility in Nevada. Our products are 100% sustainably sourced, offer premium vegan quality, gluten-free, non-psychoactive and have been proven compliant testing for microbes, heavy metals, pesticides and hazardous chemicals.
For more information on the Free Sample Pack offer, with $7.95 shipping and handling, visit the King of Hemp® website Kingofhempusa.com. Retailers and distributors interested in the product line should email [email protected] Shareholders and consumers who wish to purchase products can click here and use the discount code “PRBP8967” for a 10% discount.
Hemp, Inc.’s sales and marketing team is currently working on large scale orders for the company’s upcoming CBDA and CBGA products. Small retail stores or those looking to distribute on a large scale should email [email protected] or call 877-436-7564 for more information. The entire product line can include infused water, tinctures, gummies, capsules, edibles and more. They will come in a variety of sizes, potencies, flavors and formulas that executives anticipate will be in high demand.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those items. The Securities and Exchange Commission (SEC) requires issuers to provide “adequate current information”. Hemp, Inc.’s financial data is listed on the OTC Exchange. More information can also be found on the Hemp, Inc. website by visiting www.hempinc.com/hemp-financial-disclosures/. The materials contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements involve risks and uncertainties.
Investor Relations: 855-436-7688